The American Academy of Microbiology has elected Dr. Kyu Rhee, a professor of medicine in the Division of Infectious Diseases, to its Class of 2024. Fellows of the American Academy of Microbiology, an honorific leadership group within the American Society for Microbiology (ASM), are elected annually through a highly selective, peer-review process based on their records of scientific achievement and original contributions that have advanced microbiology.
Dr. Kyu...
A Weill Department of Medicine researcher is leading a deep dive into Medicaid program data nationwide to assess the performance of hospitals who successfully connect Medicaid patients suffering from serious injection-related infections to potentially life-saving substance use disorder treatment versus those that may not.Dr. Shashi N. Kapadia, an Assistant Professor of Medicine in the Division of Infectious Diseases, was recently...
Dr. Kyu Rhee, a professor of medicine in the Division of Infectious Diseases, has been awarded a $2.2 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) entitled “Tri-I Stimulating Access to Research in Residency program (Tri-I StARR).”The program will make it possible for clinical house staff in the Weill Department of Medicine, the Department of Pediatrics and the Department of Pathology & Laboratory Medicine purse full-time careers as...
Dr. Kyu Rhee, a distinguished physician-scientist currently a professor of medicine in the Division of Infectious Diseases in the Weill Department of Medicine, has been elected to the esteemed Association of American Physicians (AAP).Election to the AAP is one of the top honors in health and medicine, recognizing physician-scientists exhibiting excellence in the pursuit of medical knowledge and the advancement of basic or translational science...
The study is focused on whether doxycycline may slow the progression of emphysema (a type of chronic obstructive pulmonary disease), in people with well-controlled HIV who are current or former smokers.
Dr. Johnson has mentored investigators working on some of the world's most virulent infectious diseases, from HIV/AIDS to malaria, hepatitis, leptospirosis, schistosomiasis, tuberculosis, leishmaniasis, and cryptosporidiosis.
The Tri-institutional TB Research Advancement Center (TRAC) is a collaboration between an exceptional group of investigators at Weill Cornell Medicine, Cornell University, Rockefeller University, and Memorial Sloan Kettering Cancer Center.
This award was initiated by Dr. Ralph Nachman in 2002 to recognize outstanding research during fellowship training.
GHESKIO founder and the Howard and Carol Holtzmann Professor in Clinical Medicine, Dr. Jean Pape has been elected to the American Academy of Arts and Sciences.
The Weill Department of Medicine has announced five winners who will receive Fund for the Future (FFF) awards.